Close Menu

NEW YORK (GenomeWeb) – Personalis today filed an amended prospectus with the US Securities and Exchange Commission to price an initial public offering of 6.7 million shares of common stock at $14 to $16 per share.

The company has also granted the underwriters the right to purchase an additional 1 million shares of stock to cover any over-allotments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.

An opinion piece at The Hill criticizes the proposed plan to collect DNA samples from migrants at the US border.

Nature News writes that women in chemistry are less likely to have their manuscripts accepted for publication.

In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.